Title: Assistant Professor and WRHR Scholar
Primary Location: Denver
Dr. Kondapalli completed her undergraduate degree at the the University of Michigan. She received her medical degree from the University of Vermont College of Medicine where she was the recipient of the Carbee Award. During her residency training in Obstetrics and Gynecology at Northwestern University, she received the Michael Newton Award for Clinical Excellence in Obstetrics and Gynecology. Following residency, she remained at Northwestern and completed a post-doctoral research fellowship in reproductive biology. She explored the long-term consequences of cancer therapy on ovarian function and fertility, with a particular focus on improving fertility preservation options for cancer patients.
She completed her Reproductive Endocrinology and Infertility fellowship and received a Master of Science degree in Clinical Epidemiology at the University of Pennsylvania in 2011. While a fellow, she received the T32 Reproductive Epidemiology Training Grant and conducted a prospective cohort study examining metabolic and developmental outcomes in children conceived by assisted reproduction compared to spontaneous conceptions. Her research interests center on fertility preservation, ovarian response to medical therapies, and assisted reproduction outcomes. Her efforts in these fields are featured on the Oncofertility Consortium’s website, in the article Training the Next Generation in Oncofertility.
Dr. Kondapalli is board certified in Obstetrics and Gynecology, board-eligible in Reproductive Endocrinology and Infertility, and is a Fellow of the American Congress of Obstetricians and Gynecologists. She joined the faculty at the University of Colorado in 2011 as Assistant Professor and Women’s Reproductive Health Research Scholar in the Division of Reproductive Endocrinology and Infertility.
Dr. Kondapalli is also the leader of the Oncofertility Program at the University of Colorado Cancer Center where she sees patients to discuss their family planning options as cancer survivors.